SuperworthAdvanSix price to free cash flow ASIX
Market value divided by free cash flow over the last twelve months, since 2017.
- Today, Oct 23, 2026
- n/m
- not a meaningful number
- Last meaningful
- 85.1×
- May 2026
- 9-year median
- 13.9×
- 9-year range
- 4.9× to 442×
- Peer median
- 25.7×
AdvanSix's price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.
It was last meaningful in May 2026, at 85.1×.
On the days it had one over the last 9 years, its median was 13.9×, from 4.9× in Oct 2022 to 442× in Feb 2025.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 85.1× | 74.7× | 106× |
| 2025 | 15.4× | 10.2× | 442× |
| 2024 | 58.1× | 23.0× | 75.1× |
| 2023 | 27.3× | 5.1× | 28.2× |
| 2022 | 6.7× | 4.9× | 9.5× |
| 2021 | 7.4× | 6.7× | 28.2× |
| 2020 | 153× | 137× | 167× |
| 2019 | 171× | 11.0× | 208× |
| 2018 | 10.2× | 9.6× | 27.7× |
| 2017 | 25.0× | 23.5× | 34.0× |
Against its peers
Companies in Chemicals nearest AdvanSix's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| ASIXAdvanSix | n/m |
| FTKFlotek Industries | n/m |
| NAGENiagen Bioscience | n/m |
| CRONCronos | 24.8× |
| ROGRogers | 27.0× |
| FTLFFitlife Brands | 7.8× |
| NGVTIngevity | 15.5× |
| IOSPInnospec | 34.7× |
| FULFuller H B | 26.7× |
| WDFCWD 40 | 35.9× |
| AVNTAvient | 19.7× |
| Peer median | 25.7× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on AdvanSix
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.